Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, October 29, 2014 9:24:28 AM
bullish very long term
$PCYC recent news/filings
## source: finance.yahoo.com
Tue, 28 Oct 2014 22:27:30 GMT ~ Pharmacyclics Announces Conference Call to Discuss Third Quarter Financial Results
[at noodls] - SUNNYVALE, Calif., Oct. 28, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that it will hold a conference call and audio webcast to discuss its financial results for the third ...
read full: http://www.noodls.com/view/346B96EC29F7E11FBBE7F6B4AF572C356E1F38D6
*********************************************************
Wed, 22 Oct 2014 17:40:03 GMT ~ Pharmacyclics Up on Label Expansion Efforts for Imbruvica
read full: http://finance.yahoo.com/news/pharmacyclics-label-expansion-efforts-imbruvica-174003373.html
*********************************************************
Mon, 20 Oct 2014 12:53:47 GMT ~ PHARMACYCLICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/141020/pcyc8-k.html
*********************************************************
Mon, 20 Oct 2014 12:13:47 GMT ~ Pharmacyclics Files Supplemental New Drug Application for IMBRUVICA® for Waldenstrom's Macroglobulinemia
[at noodls] - SUNNYVALE, Calif., Oct. 20, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration ...
read full: http://www.noodls.com/view/AC3F7A83039CCE6D66CB11480FC277CC2FACC79E
*********************************************************
Mon, 20 Oct 2014 12:00:00 GMT ~ Pharmacyclics Files Supplemental New Drug Application for IMBRUVICA® for Waldenstrom's Macroglobulinemia
[PR Newswire] - SUNNYVALE, Calif., Oct. 20, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration ...
read full: http://finance.yahoo.com/news/pharmacyclics-files-supplemental-drug-application-120000771.html
*********************************************************
$PCYC charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$PCYC company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/PCYC/company-info
Ticker: $PCYC
OTC Market Place: Not Available
CIK code: 0000949699
Company name: Pharmacyclics, Inc.
Incorporated In: DE, USA
$PCYC share structure
## source: otcmarkets.com
Market Value: $9,849,069,817 a/o Oct 28, 2014
Shares Outstanding: 75,269,926 a/o Jul 29, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.0001
$PCYC extra dd links
Company name: Pharmacyclics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PCYC+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PCYC+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PCYC+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PCYC/news - http://finance.yahoo.com/q/h?s=PCYC+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PCYC/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PCYC/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PCYC+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PCYC
DTCC (dtcc.com): http://search2.dtcc.com/?q=Pharmacyclics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Pharmacyclics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Pharmacyclics%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PCYC
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000949699&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PCYC/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PCYC/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PCYC&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PCYC
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PCYC/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PCYC+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PCYC+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PCYC
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PCYC
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PCYC+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PCYC/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PCYC+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PCYC.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PCYC
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PCYC/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PCYC/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PCYC
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PCYC
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PCYC:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PCYC
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PCYC
$PCYC DD Notes ~ http://www.ddnotesmaker.com/PCYC
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM